OCUL — Ocular Therapeutix, Inc. stock price, charts and financials

QT16Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.59
+0.19+2.26%
OverviewShort InterestFilings
OCULQT16Ocular Therapeutix, Inc.·NASDAQ
8.59+2.26%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026S-8Registration of employee benefit securities
Aug 03, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 18, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 202610-QQuarterly report
May 05, 20268-KCurrent report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026ARSAnnual report to shareholders
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 13, 20264Statement of changes in beneficial ownership
#1 / 25 of 332
Page
▼
/ 14